CRMD logo

CorMedix (CRMD) EBITDA

Annual EBITDA

-$46.23 M
-$16.06 M-53.21%

December 31, 2023


Summary


Performance

CRMD EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCRMDprofitabilitymetrics:

Quarterly EBITDA

-$2.69 M
+$11.38 M+80.88%

September 30, 2024


Summary


Performance

CRMD Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCRMDprofitabilitymetrics:

TTM EBITDA

-$47.32 M
+$7.02 M+12.93%

September 30, 2024


Summary


Performance

CRMD TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCRMDprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CRMD EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-53.2%+81.7%-2.3%
3 y3 years-71.0%+67.1%-56.8%
5 y5 years-72.8%+54.2%-84.4%

CRMD EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-57.4%at lowat high+83.0%-62.1%+12.9%
5 y5-year-124.1%at lowat high+83.0%-129.3%+12.9%
alltimeall time-1445.9%at low-176.6%+83.9%-7343.1%+12.9%

CorMedix EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.69 M(-80.9%)
-$47.32 M(-12.9%)
Jun 2024
-
-$14.07 M(-11.1%)
-$54.34 M(+5.5%)
Mar 2024
-
-$15.83 M(+7.5%)
-$51.52 M(+11.4%)
Dec 2023
-$46.23 M(+53.2%)
-$14.73 M(+51.6%)
-$46.23 M(+16.5%)
Sep 2023
-
-$9.71 M(-13.7%)
-$39.68 M(+7.9%)
Jun 2023
-
-$11.25 M(+6.7%)
-$36.79 M(+9.1%)
Mar 2023
-
-$10.54 M(+28.9%)
-$33.71 M(+11.7%)
Dec 2022
-$30.18 M(+2.7%)
-$8.18 M(+19.8%)
-$30.18 M(+1.4%)
Sep 2022
-
-$6.82 M(-16.4%)
-$29.76 M(-5.5%)
Jun 2022
-
-$8.17 M(+16.5%)
-$31.49 M(+7.9%)
Mar 2022
-
-$7.01 M(-9.7%)
-$29.19 M(-0.7%)
Dec 2021
-$29.38 M(+8.7%)
-$7.77 M(-9.1%)
-$29.38 M(+6.4%)
Sep 2021
-
-$8.55 M(+45.6%)
-$27.62 M(+7.7%)
Jun 2021
-
-$5.87 M(-18.5%)
-$25.65 M(-10.6%)
Mar 2021
-
-$7.20 M(+20.0%)
-$28.70 M(+6.2%)
Dec 2020
-$27.04 M(+31.0%)
-$6.00 M(-8.8%)
-$27.04 M(+2.7%)
Sep 2020
-
-$6.58 M(-26.2%)
-$26.32 M(+6.1%)
Jun 2020
-
-$8.92 M(+61.2%)
-$24.81 M(+16.4%)
Mar 2020
-
-$5.53 M(+4.8%)
-$21.32 M(+3.3%)
Dec 2019
-$20.63 M(-22.9%)
-$5.28 M(+4.0%)
-$20.63 M(+56.5%)
Sep 2019
-
-$5.08 M(-6.5%)
-$13.19 M(-28.1%)
Jun 2019
-
-$5.43 M(+12.1%)
-$18.33 M(-14.5%)
Mar 2019
-
-$4.85 M(-323.7%)
-$21.44 M(-19.9%)
Dec 2018
-$26.75 M(-18.8%)
$2.17 M(-121.2%)
-$26.75 M(-31.8%)
Sep 2018
-
-$10.22 M(+19.7%)
-$39.22 M(+0.7%)
Jun 2018
-
-$8.54 M(-16.0%)
-$38.94 M(+9.6%)
Mar 2018
-
-$10.16 M(-1.3%)
-$35.54 M(+7.8%)
Dec 2017
-$32.97 M(+33.9%)
-$10.30 M(+3.5%)
-$32.97 M(+13.4%)
Sep 2017
-
-$9.94 M(+93.6%)
-$29.06 M(+2.9%)
Jun 2017
-
-$5.14 M(-32.3%)
-$28.23 M(+0.9%)
Mar 2017
-
-$7.59 M(+18.7%)
-$27.98 M(+14.2%)
DateAnnualQuarterlyTTM
Dec 2016
-$24.62 M(+35.5%)
-$6.39 M(-29.9%)
-$24.50 M(+11.5%)
Sep 2016
-
-$9.12 M(+86.7%)
-$21.97 M(+25.3%)
Jun 2016
-
-$4.88 M(+18.7%)
-$17.54 M(+4.5%)
Mar 2016
-
-$4.11 M(+6.5%)
-$16.78 M(-7.6%)
Dec 2015
-$18.17 M(-11.1%)
-$3.86 M(-17.6%)
-$18.17 M(+10.0%)
Sep 2015
-
-$4.68 M(+13.5%)
-$16.51 M(-2.0%)
Jun 2015
-
-$4.13 M(-24.9%)
-$16.86 M(+82.9%)
Mar 2015
-
-$5.49 M(+148.6%)
-$9.22 M(-54.9%)
Dec 2014
-$20.44 M(+166.0%)
-$2.21 M(-56.0%)
-$20.43 M(-5.5%)
Sep 2014
-
-$5.02 M(-243.1%)
-$21.63 M(+15.1%)
Jun 2014
-
$3.51 M(-121.0%)
-$18.79 M(-20.3%)
Mar 2014
-
-$16.71 M(+391.3%)
-$23.59 M(+207.0%)
Dec 2013
-$7.68 M(+156.9%)
-$3.40 M(+55.5%)
-$7.68 M(+60.9%)
Sep 2013
-
-$2.19 M(+69.6%)
-$4.78 M(+33.5%)
Jun 2013
-
-$1.29 M(+59.9%)
-$3.58 M(+23.4%)
Mar 2013
-
-$806.10 K(+63.4%)
-$2.90 M(-3.0%)
Dec 2012
-$2.99 M(-58.2%)
-$493.20 K(-50.1%)
-$2.99 M(+14.7%)
Sep 2012
-
-$989.10 K(+61.8%)
-$2.61 M(-38.1%)
Jun 2012
-
-$611.20 K(-31.9%)
-$4.22 M(-30.6%)
Mar 2012
-
-$897.20 K(+712.7%)
-$6.08 M(-15.0%)
Dec 2011
-$7.15 M(-11.5%)
-$110.40 K(-95.7%)
-$7.15 M(-22.2%)
Sep 2011
-
-$2.60 M(+5.0%)
-$9.19 M(+15.1%)
Jun 2011
-
-$2.47 M(+25.5%)
-$7.99 M(+19.5%)
Mar 2011
-
-$1.97 M(-8.3%)
-$6.68 M(-17.3%)
Dec 2010
-$8.08 M(+33.7%)
-$2.15 M(+54.7%)
-$8.08 M(-18.4%)
Sep 2010
-
-$1.39 M(+18.8%)
-$9.90 M(+6.2%)
Jun 2010
-
-$1.17 M(-65.3%)
-$9.32 M(+6.1%)
Mar 2010
-
-$3.37 M(-15.0%)
-$8.78 M(+45.3%)
Dec 2009
-$6.04 M
-$3.97 M(+388.9%)
-$6.04 M(+190.9%)
Sep 2009
-
-$811.30 K(+28.8%)
-$2.08 M(+64.1%)
Jun 2009
-
-$630.10 K(-0.9%)
-$1.27 M(+99.1%)
Mar 2009
-
-$635.70 K
-$635.70 K

FAQ

  • What is CorMedix annual EBITDA?
  • What is the all time high annual EBITDA for CorMedix?
  • What is CorMedix annual EBITDA year-on-year change?
  • What is CorMedix quarterly EBITDA?
  • What is the all time high quarterly EBITDA for CorMedix?
  • What is CorMedix quarterly EBITDA year-on-year change?
  • What is CorMedix TTM EBITDA?
  • What is the all time high TTM EBITDA for CorMedix?
  • What is CorMedix TTM EBITDA year-on-year change?

What is CorMedix annual EBITDA?

The current annual EBITDA of CRMD is -$46.23 M

What is the all time high annual EBITDA for CorMedix?

CorMedix all-time high annual EBITDA is -$2.99 M

What is CorMedix annual EBITDA year-on-year change?

Over the past year, CRMD annual EBITDA has changed by -$16.06 M (-53.21%)

What is CorMedix quarterly EBITDA?

The current quarterly EBITDA of CRMD is -$2.69 M

What is the all time high quarterly EBITDA for CorMedix?

CorMedix all-time high quarterly EBITDA is $3.51 M

What is CorMedix quarterly EBITDA year-on-year change?

Over the past year, CRMD quarterly EBITDA has changed by +$12.04 M (+81.74%)

What is CorMedix TTM EBITDA?

The current TTM EBITDA of CRMD is -$47.32 M

What is the all time high TTM EBITDA for CorMedix?

CorMedix all-time high TTM EBITDA is -$635.70 K

What is CorMedix TTM EBITDA year-on-year change?

Over the past year, CRMD TTM EBITDA has changed by -$1.08 M (-2.34%)